התחייבויות שוטפות של החברה: MediWound Ltd. (MDWD)

MediWound Ltd. (MDWD) is developing unique enzyme solutions for the therapy of chronic wounds and burns, which allows the company to maintain high margins regardless of market dumping. Growth prospects rely on the implementation of these methods in hospitals and the success of tissue regeneration tests. The current indicator stands at 0.00, and the price trend on GURU.Markets shown in this chart visualizes the dynamics of the company's debt.

MediWound Ltd. (MDWD) is developing a biopharmaceutical wound care system where the high cost for medical centers to switch protocols creates a steady cash flow. By analyzing the short-term debt trend, an investor can observe the repayment dynamics of urgent loans. This metric is calculated daily by discounting future prospects while accounting for order book liquidity. An increase in liabilities signals a risk of a price drawdown, which allows for an assessment of the company's capital stability.